Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises
2024 marked another significant year in China’s intellectual property law space. Danlei Wu of Fangda Partners examines the key developments and the indicators for further developments in the year ahead
Regulatory ratings of insurance companies include corporate governance, solvency, liability quality and asset quality / CLP Reference: 3910/25.01.07 ; Issued: 2025-01-07 ; Effective: 2025-03-01
Data centers are required to safeguard the security of the customer’s own training datasets / Issued: 2025-01-13
CSRC clarifies on the shareholding changes in takeovers of listed companies. / CLP Reference: 3700/25.01.10 ; Issued: 2025-01-10 ; Effective: 2025-01-10
Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications
Casper Sek of Jingtian & Gongcheng examines the evolution and refinement of China’s data protection oversight throughout 2024
Simon Leung, Partner of Baker McKenzie, and Terry Xu, Senior Counsel at FenXun Partners, examine key regulatory shifts in 2024 and provide an outlook of potential regulatory trends for the banking and finance sector in 2025
Chinese EV maker Geely expands into Brazil through a partnership with France’s Renault; The parent company of Calvin Klein and Tommy Hilfiger is blacklisted by China; and Canadian Solar is sued by China’s Trina Solar over patent infringement.
China Law & Practice Awards 2024 sees a broad spectrum of law firms seize crown in individual practices. Fangda Partners and Clifford Chance win top accolades in the 18th annual CLP Awards.
